- Home
- UPWK vs CERT Comparison
UPWK vs CERT Comparison
Compare UPWK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPWK | CERT |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UPWK | CERT |
|---|---|---|
| Price | $9.01 | $8.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $22.73 | $11.67 |
| AVG Volume (30 Days) | ★ 3.7M | 3.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $787,784,000.00 | $418,838,000.00 |
| Revenue This Year | $9.06 | $4.18 |
| Revenue Next Year | $13.57 | $5.39 |
| P/E Ratio | $20.27 | ★ N/A |
| Revenue Growth | 2.40 | ★ 8.75 |
| 52 Week Low | $7.44 | $4.45 |
| 52 Week High | $22.84 | $13.88 |
Technical Indicators
Market Signals| Indicator | UPWK | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 59.16 |
| Support Level | $8.48 | $7.94 |
| Resistance Level | $9.32 | $8.39 |
| Average True Range (ATR) | 0.37 | 0.31 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 92.98 | 50.49 |
Price Performance
Historical ComparisonAbout UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.